Clinical Trial

A Prospective Study on the Treatment of cLM Based on ICG Imaging

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 18, 2026 (before its estimated March 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM. Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation. Researchers will compare difference in curative effect between two groups.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-16; most recent amendment 2026-02-15.
Trial Details
NCT Number NCT06275022
Lead Sponsor Nanjing Children's Hospital
Conditions Lymphatic Malformation
Enrollment 110 participants
Start Date 2023-01-01
Primary Completion 2026-03-20 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-18